Circulating inflammatory biomarkers, adipokines and breast cancer risk—a case-control study nested within the EPIC cohort

Manon Cairat(Université de Bordeaux), Laure Dossus(World Health Organization - Lyon Office), Pilar Amiano Etxezarreta(Basque Government), Carine Biessy(World Health Organization), Evelyn M. Monninkhof(Utrecht University), Krasimira Aleksandrova(Leibniz Institute for Prevention Research and Epidemiology - BIPS), Sabina Rinaldi(St. Elizabeth's Hospital), Anouk E. Hiensch(Utrecht University), Antonio Agudo(Institut Català d'Oncologia), Ruth C. Travis(University of Oxford), Rudolf Kaaks(German Cancer Research Center), Matthias B. Schulze(Brigham and Women's Hospital), Amalia Mattiello(University of Naples Federico II), A. Fournier(Inserm), ­Rosario ­Tumino(Azienda Usl 8 Arezzo), Sabina Sieri(Fondazione G.B. Bietti), Chiara Grasso(University of Turin), Giovanna Masala(Piedmont Reference Center for Epidemiology and Cancer Prevention), Inger Torhild Gram(St. Elizabeth's Hospital), Renée T. Fortner(Norwegian Institute of Public Health), Vivian Viallon(Centre international de recherche sur le cancer), Marina Kvaskoff(Inserm), Aurelio Barricarte(Instituto de Salud Pública de Navarra), Marc J. Gunter(Centre international de recherche sur le cancer), Anne‐Sophie Navionis(Centre international de recherche sur le cancer), David C. Muller(UNSW Sydney), Anja Olsen(Danish Cancer Society), Elisabete Weiderpass(Centre international de recherche sur le cancer), Anne Tjønneland(University of Copenhagen), Gianluca Severi(Inserm), María‐José Sánchez(Instituto de Investigación Biosanitaria de Granada), Karina Standahl Olsen(UiT The Arctic University of Norway), Carmen Santiuste(Instituto Murciano de Investigación Biosanitaria), Isabelle Romieu(Johns Hopkins University), Melissa A. Merritt(The University of Sydney)
BMC Medicine
April 18, 2022
Cited by 27


Related Papers